These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9205461)

  • 1. Distribution of intraperitoneal chemotherapy into the pleural cavity.
    Vaccarello L; Berghella V; Rubin SC; Hoskins WJ
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):714-7. PubMed ID: 9205461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
    Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
    Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
    Molucon-Chabrot C; Isambert N; Benoit L; Zanetta S; Fraisse J; Guilland JC; Royer B; Monin-Baroille P; Flesch M; Fargeot P; Coudert B; Mayer F; Fumoleau P; Chauffert B
    Anticancer Drugs; 2006 Nov; 17(10):1211-7. PubMed ID: 17075321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
    Myers CE
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
    Kehoe SM; Williams NL; Yakubu R; Levine DA; Chi DS; Sabbatini PJ; Aghajanian CA; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2009 May; 113(2):228-32. PubMed ID: 19254808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bowel injury caused by a catheter for Intraperitoneal chemotherapy--a case report].
    Yamauchi I; Higashi M; Yoshioka M; Koyama N; Hashimoto M; Takahashi K; Nakamura Y
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1713-6. PubMed ID: 8886051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer.
    Hydzik C
    Clin J Oncol Nurs; 2007 Apr; 11(2):221-5. PubMed ID: 17573271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment.
    Markman M; Walker JL
    J Clin Oncol; 2006 Feb; 24(6):988-94. PubMed ID: 16461779
    [No Abstract]   [Full Text] [Related]  

  • 9. The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
    Naumann RW; Alvarez RD; Partridge EE; Kilgore LC; Austin JM
    Gynecol Oncol; 1993 Sep; 50(3):291-3. PubMed ID: 8406189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model.
    Katano K; Tsujitani S; Oka S; Saito H; Gomyo Y; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(3A):1603-7. PubMed ID: 10928078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nursing perspectives on intraperitoneal chemotherapy.
    Hoff ST
    J Intraven Nurs; 1991; 14(5):309-14. PubMed ID: 1748914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraperitoneal Chemotherapy--a new treatment method of ovarian cancer patients].
    Menczer J; Brenner H
    Harefuah; 1985 Oct; 109(7-8):202-4. PubMed ID: 4076921
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraperitoneal chemotherapy: a reemerging approach in the treatment of ovarian cancer.
    Drake B
    J Infus Nurs; 2009; 32(6):314-22. PubMed ID: 19918140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
    Almadrones L
    Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understand the benefits and risks of intraperitoneal therapy for advanced ovarian cancer.
    Oestreicher P
    ONS Connect; 2007 Apr; 22(4):24-5. PubMed ID: 17477008
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intraperitoneal cisplatin chemotherapy for ovarian cancer].
    Hayashi H; Nishii H; Ueda K; Kunitou S; Wada S; Takanashi H; Kobayashi S; Yasuda M
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2043-8. PubMed ID: 11791382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of intraperitoneal drug distribution during intraperitoneal chemotherapy using saline-injected MR imaging through an implanted catheter-port system].
    Obuchi M; Shimizu A; Fujiwara T; Sugimoto H; Honda M; Kubota H; Yamamoto W; Kinebuchi Y
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1891-5. PubMed ID: 11729482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
    Black D; Levine DA; Nicoll L; Chou JF; Iasonos A; Brown CL; Sonoda Y; Chi DS; Leitao MM; Abu-Rustum NR; Ferguson SE; Barakat RR
    Gynecol Oncol; 2008 Apr; 109(1):39-42. PubMed ID: 18234300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Care of ovarian cancer treated with intraperitoneal chemotherapy].
    Meng FH
    Zhonghua Hu Li Za Zhi; 1994 Jan; 29(1):24-6. PubMed ID: 7788741
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complications following implantatation of a Tenckhoff catheter for the intraperitoneal administration of chemotherapeutic agents].
    de Graaf PW; ten Bokkel Huinink WW; Aartsen EJ; Mellema MM; Dubbelman R; Hart AA
    Ned Tijdschr Geneeskd; 1987 Feb; 131(8):323-6. PubMed ID: 3561578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.